# Acamprosate Calcium

NDC: 0378-6333
Generic name: acamprosate calcium enteric-coated
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20140924

FDA application: ANDA200142

## Active ingredients

- ACAMPROSATE CALCIUM: 333 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-6333"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-6333
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75ddfd10-55b2-426e-bc74-3413cd0d7c94